Bioinformatics and Immunohistochemical Analyses Support Preserved Expression of Glial Cell Line-Derived Neurotrophic Factor Receptor RET in Parkinson's

Mov Disord. 2023 Jun;38(6):1115-1116. doi: 10.1002/mds.29443.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computational Biology
  • Glial Cell Line-Derived Neurotrophic Factor
  • Glial Cell Line-Derived Neurotrophic Factor Receptors
  • Humans
  • Parkinson Disease*
  • Proto-Oncogene Proteins c-ret / genetics

Substances

  • Glial Cell Line-Derived Neurotrophic Factor Receptors
  • Glial Cell Line-Derived Neurotrophic Factor
  • RET protein, human
  • Proto-Oncogene Proteins c-ret